IS7663A - Starfrænar hjartavöðvafrumur úr mannafósturstofnfrumum - Google Patents

Starfrænar hjartavöðvafrumur úr mannafósturstofnfrumum

Info

Publication number
IS7663A
IS7663A IS7663A IS7663A IS7663A IS 7663 A IS7663 A IS 7663A IS 7663 A IS7663 A IS 7663A IS 7663 A IS7663 A IS 7663A IS 7663 A IS7663 A IS 7663A
Authority
IS
Iceland
Prior art keywords
embryonic stem
human embryonic
heart muscle
cells
stem cells
Prior art date
Application number
IS7663A
Other languages
English (en)
Inventor
A. Thomson James
J. Kamp Timothy
Ma Yue
He Jia-Qiang
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Publication of IS7663A publication Critical patent/IS7663A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5061—Muscle cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IS7663A 2002-07-26 2005-01-25 Starfrænar hjartavöðvafrumur úr mannafósturstofnfrumum IS7663A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39933002P 2002-07-26 2002-07-26
PCT/US2003/023174 WO2004011603A2 (en) 2002-07-26 2003-07-25 Functional cardiomyocytes from human embryonic stem cells

Publications (1)

Publication Number Publication Date
IS7663A true IS7663A (is) 2005-01-25

Family

ID=31188569

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7663A IS7663A (is) 2002-07-26 2005-01-25 Starfrænar hjartavöðvafrumur úr mannafósturstofnfrumum

Country Status (14)

Country Link
US (1) US7611852B2 (is)
EP (1) EP1551991A4 (is)
JP (1) JP2005533518A (is)
KR (1) KR20050026008A (is)
CN (1) CN1671860A (is)
AU (1) AU2003252155B2 (is)
BR (1) BR0312764A (is)
CA (1) CA2493588C (is)
IL (1) IL165943A0 (is)
IS (1) IS7663A (is)
MX (1) MXPA05000283A (is)
NO (1) NO20051030L (is)
NZ (1) NZ537245A (is)
WO (1) WO2004011603A2 (is)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030224345A1 (en) * 2001-08-24 2003-12-04 Advanced Cell Technology Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy
US8263375B2 (en) 2002-12-20 2012-09-11 Acea Biosciences Dynamic monitoring of activation of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) in living cells using real-time microelectronic cell sensing technology
US10215748B2 (en) 2002-12-20 2019-02-26 Acea Biosciences, Inc. Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways
US10551371B2 (en) 2003-11-10 2020-02-04 Acea Biosciences, Inc. System and method for monitoring cardiomyocyte beating, viability and morphology and for screening for pharmacological agents which may induce cardiotoxicity or modulate cardiomyocyte function
US11346797B2 (en) 2002-12-20 2022-05-31 Agilent Technologies, Inc. System and method for monitoring cardiomyocyte beating, viability, morphology and electrophysiological properties
US10539523B2 (en) 2002-12-20 2020-01-21 Acea Biosciences, Inc. System and method for monitoring cardiomyocyte beating, viability, morphology, and electrophysiological properties
AU2003901099A0 (en) * 2003-03-11 2003-03-27 Es Cell International Pte Ltd. Methods of inducing differentiation of stem cells
CA2550274A1 (en) 2003-11-12 2005-05-26 Acea Biosciences, Inc. Real time electronic cell sensing systems and applications for cell-based assays
JP5074921B2 (ja) 2004-04-07 2012-11-14 アキシオジェネシス エージー 非侵襲性生体外機能組織検定システム
ES2770067T3 (es) 2004-05-11 2020-06-30 Ncardia Ag Descubrimiento de fármacos basado en células diferenciadas in vitro
US20050277124A1 (en) * 2004-06-10 2005-12-15 White Steven M Cardiac conduction system cells and uses thereof
WO2008090472A2 (en) * 2007-01-25 2008-07-31 Uti Limited Partnership Tissue progenitor cells that overexpress erg
US8153427B2 (en) * 2007-03-15 2012-04-10 California Stem Cell, Inc. Cardiomyocytes and methods of producing and purifying cardiomyocytes
US8202720B2 (en) * 2007-06-08 2012-06-19 Mitsubishi Chemical Medience Corporation Model cell chip, apparatus for evaluating drug effect using the model cell chip and method of evaluating drug effect
CA2723223C (en) 2008-05-05 2017-06-06 Acea Biosciences, Inc. Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution
US8603817B2 (en) 2008-11-03 2013-12-10 University Of Washington Induction of human embryonic stem cell derived cardiac pacemaker or chamber-type cardiomyocytes by manipulation of neuregulin signaling
EP2218772A1 (en) 2009-02-09 2010-08-18 Koninklijke Philips Electronics N.V. Cardiomyocytes-containing device and method for manufacturing the same
WO2010094694A1 (en) * 2009-02-23 2010-08-26 F. Hoffmann-La Roche Ag Assays to predict cardiotoxicity
WO2011146531A1 (en) * 2010-05-18 2011-11-24 Acea Biosciences, Inc Data analysis of impedance-based cardiomyocyte-beating signals as detected on real-time cell analysis (rtca) cardio instruments
AU2010355614B2 (en) * 2010-06-13 2015-07-02 Institute Of Biophysics, Chinese Academy Of Sciences Methods and compositions for preparing cardiomyocytes from stem cells and uses thereof
EP2601524B1 (en) * 2010-08-05 2014-06-25 Koninklijke Philips N.V. Cardiomyocyte containing device, manufacturing method and measuring method
KR101364965B1 (ko) * 2010-10-06 2014-02-18 (주)차바이오앤디오스텍 인간 배아줄기세포 유래 심근세포의 배양 및 정제 방법
CA2815108A1 (en) * 2010-10-29 2012-05-03 Rory Abrams Method of determining risk of arrythmia
US9155765B2 (en) 2011-07-05 2015-10-13 Baylor Research Institute Establishment of patient- or person-specific cardiac myocyte cell lines from human induced pluripotent stem cells (iPSCs)
KR101966208B1 (ko) 2011-07-21 2019-04-09 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 환자로부터 유도 만능 줄기 세포들로부터의 심근 세포 및 그 사용 방법
CN104237308B (zh) * 2013-06-09 2016-08-31 国家纳米科学中心 一种在体外筛选药物的方法
US9983198B2 (en) * 2015-03-19 2018-05-29 Axion Biosystems, Inc. Systems and methods for assessing data collected from an electrically active cell culture
US12066428B2 (en) 2015-11-20 2024-08-20 Agilent Technologies, Inc. Cell-substrate impedance monitoring of cancer cells
WO2017147536A1 (en) 2016-02-24 2017-08-31 The Rockefeller University Embryonic cell-based therapeutic candidate screening systems, models for huntington's disease and uses thereof
EP3589299B1 (en) * 2017-03-03 2025-04-09 Agilent Technologies, Inc. METHODS AND SYSTEMS FOR FUNCTIONAL MATURATION OF iPSC AND ESC DERIVED CARDIOMYOCYTES
GB202000903D0 (en) 2020-01-22 2020-03-04 Univ Oxford Innovation Ltd Process for producing cardiomyocytes
USD941488S1 (en) 2020-02-07 2022-01-18 Agilent Technologies, Inc. Instrument for analyzing biological cells
US20210301245A1 (en) 2020-03-29 2021-09-30 Agilent Technologies, Inc. Systems and methods for electronically and optically monitoring biological samples

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4441327C1 (de) 1994-11-22 1995-11-09 Inst Pflanzengenetik & Kultur Embryonale Herzmuskelzellen, ihre Herstellung und ihre Verwendung
DE19727962A1 (de) * 1997-07-02 1999-01-14 Juergen Hescheler Fluoreszierende Proteine als zelltypspezifische Reporter
DE19843234A1 (de) * 1998-09-09 2000-03-23 Inst Pflanzengenetik & Kultur Differenzierte Herzzellen mit pathologischen Merkmalen als in vitro-Modell für Herzerkrankungen
AU2002354893A1 (en) * 2001-07-20 2003-03-03 Technion Research And Development Foundation Ltd. Methods of generating human cardiac cells and tissues and uses thereof
US20050244384A1 (en) 2002-04-01 2005-11-03 Law Peter K Cellular transplantation for heart regeneration

Also Published As

Publication number Publication date
CA2493588A1 (en) 2004-02-05
AU2003252155B2 (en) 2009-01-22
US7611852B2 (en) 2009-11-03
NO20051030L (no) 2005-04-07
IL165943A0 (en) 2006-01-15
CN1671860A (zh) 2005-09-21
MXPA05000283A (es) 2005-03-31
AU2003252155A1 (en) 2004-02-16
KR20050026008A (ko) 2005-03-14
CA2493588C (en) 2012-09-11
WO2004011603A2 (en) 2004-02-05
WO2004011603A3 (en) 2004-07-08
NZ537245A (en) 2010-04-30
BR0312764A (pt) 2005-07-26
JP2005533518A (ja) 2005-11-10
US20040106095A1 (en) 2004-06-03
EP1551991A2 (en) 2005-07-13
EP1551991A4 (en) 2006-09-20

Similar Documents

Publication Publication Date Title
DK2298237T3 (da) Hjerteprotese
EP1702247A4 (en) HEART VALVE REPOSITIONABLE
EP1530449A4 (en) Artificial cornea
PL377590A1 (pl) Nowe zastosowanie erytropoetyny w chorobach serca
CL2003002417A1 (es) Tratamiento de tejido con celulas mesenquimales indifereenciadas
DE60316652D1 (de) Endoskop
DE60312054D1 (de) Prothese
DE60324178D1 (de) THIAZOLIDIN-4-ONES UM hYAK3 PROTEINEN ZU HEMMEN
DE60304102D1 (de) Hautreinigungszusammensetzung
AU2003241291A8 (en) Vascularized human skin equivalent
IL165943A0 (en) Functional cardiomyocytes from human embryonic stem cells
DE60311298D1 (de) Kopfhautbehandlung
DK1576091T3 (da) Human adult olefaktorisk stamcelle
EP1708757A4 (en) USE OF PLURIPOTENTIAL CELLS TAKEN FROM HUMAN CORDIAL BLOOD BLOOD FOR THE TREATMENT OF DISEASE
EP1551225A4 (en) KRYOKONSERVATION OF HAPEN-MODIFIED TUMOR CELLS
ATE389742T1 (de) Gewebebehandlungsmittel
DE602004015552D1 (de) Körperfettmessgerät
EP1500694A4 (en) LUBRICANT COMPOSITION
DE50211671D1 (de) Implantierbare Prothese
DE60318635D1 (de) Herzstimulationsvorrichtung
DE60312992D1 (de) Medizinisches implantat
DE112004002142D2 (de) Hautcreme
DE50301087D1 (de) Herzhalter
AU2003286808A8 (en) Dopamine neurons from human embryonic stem cells
DE602004022100D1 (de) Stimulationshilfe